HEALTHglobal
An engineered <i>E. coli</i> strain sustains intratumoral nitric oxide production to boost effectiveness of tumor immunotherapy
Single source
Updated 2 hours ago
First seen March 18, 2026 19:35:32Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.